![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: POLD4 |
Gene summary for POLD4 |
![]() |
Gene information | Species | Human | Gene symbol | POLD4 | Gene ID | 57804 |
Gene name | DNA polymerase delta 4, accessory subunit | |
Gene Alias | POLDS | |
Cytomap | 11q13.2 | |
Gene Type | protein-coding | GO ID | GO:0000731 | UniProtAcc | Q9HCU8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57804 | POLD4 | sample3 | Human | Cervix | CC | 1.41e-36 | 6.21e-01 | 0.1387 |
57804 | POLD4 | T3 | Human | Cervix | CC | 3.26e-34 | 6.11e-01 | 0.1389 |
57804 | POLD4 | LZE2D | Human | Esophagus | HGIN | 2.47e-07 | 7.14e-01 | 0.0642 |
57804 | POLD4 | LZE2T | Human | Esophagus | ESCC | 5.41e-13 | 1.15e+00 | 0.082 |
57804 | POLD4 | LZE3D | Human | Esophagus | HGIN | 3.66e-03 | 8.39e-01 | 0.0668 |
57804 | POLD4 | LZE4T | Human | Esophagus | ESCC | 9.50e-45 | 1.15e+00 | 0.0811 |
57804 | POLD4 | LZE5T | Human | Esophagus | ESCC | 6.29e-25 | 1.30e+00 | 0.0514 |
57804 | POLD4 | LZE7T | Human | Esophagus | ESCC | 7.39e-21 | 6.77e-01 | 0.0667 |
57804 | POLD4 | LZE8T | Human | Esophagus | ESCC | 1.68e-29 | 7.58e-01 | 0.067 |
57804 | POLD4 | LZE20T | Human | Esophagus | ESCC | 1.79e-55 | 1.80e+00 | 0.0662 |
57804 | POLD4 | LZE21D1 | Human | Esophagus | HGIN | 2.08e-07 | 8.39e-01 | 0.0632 |
57804 | POLD4 | LZE22D1 | Human | Esophagus | HGIN | 2.86e-21 | 8.32e-01 | 0.0595 |
57804 | POLD4 | LZE22T | Human | Esophagus | ESCC | 3.07e-26 | 1.23e+00 | 0.068 |
57804 | POLD4 | LZE24T | Human | Esophagus | ESCC | 5.27e-75 | 2.08e+00 | 0.0596 |
57804 | POLD4 | LZE22D3 | Human | Esophagus | HGIN | 1.28e-05 | 9.39e-01 | 0.0653 |
57804 | POLD4 | LZE21T | Human | Esophagus | ESCC | 2.11e-16 | 8.45e-01 | 0.0655 |
57804 | POLD4 | LZE6T | Human | Esophagus | ESCC | 8.64e-38 | 1.26e+00 | 0.0845 |
57804 | POLD4 | P1T-E | Human | Esophagus | ESCC | 6.53e-41 | 1.35e+00 | 0.0875 |
57804 | POLD4 | P2T-E | Human | Esophagus | ESCC | 9.37e-25 | 4.63e-01 | 0.1177 |
57804 | POLD4 | P4T-E | Human | Esophagus | ESCC | 6.48e-85 | 1.69e+00 | 0.1323 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | CRC | ![]() |
Stomach | GC | ![]() |
Stomach | CAG with IM | ![]() |
Stomach | CSG | ![]() |
Stomach | CAG | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00062602 | Cervix | CC | DNA replication | 48/2311 | 260/18723 | 2.70e-03 | 1.85e-02 | 48 |
GO:007189710 | Esophagus | HGIN | DNA biosynthetic process | 44/2587 | 180/18723 | 8.97e-05 | 1.96e-03 | 44 |
GO:00062604 | Esophagus | ESCC | DNA replication | 181/8552 | 260/18723 | 3.55e-15 | 2.05e-13 | 181 |
GO:007189716 | Esophagus | ESCC | DNA biosynthetic process | 127/8552 | 180/18723 | 1.04e-11 | 3.85e-10 | 127 |
GO:00062612 | Esophagus | ESCC | DNA-dependent DNA replication | 100/8552 | 151/18723 | 2.61e-07 | 3.94e-06 | 100 |
GO:00062601 | Liver | HCC | DNA replication | 146/7958 | 260/18723 | 5.68e-06 | 7.02e-05 | 146 |
GO:00718975 | Liver | HCC | DNA biosynthetic process | 99/7958 | 180/18723 | 4.66e-04 | 3.08e-03 | 99 |
GO:0006261 | Liver | HCC | DNA-dependent DNA replication | 80/7958 | 151/18723 | 5.91e-03 | 2.44e-02 | 80 |
GO:00062603 | Oral cavity | OSCC | DNA replication | 159/7305 | 260/18723 | 3.25e-13 | 1.59e-11 | 159 |
GO:00718979 | Oral cavity | OSCC | DNA biosynthetic process | 106/7305 | 180/18723 | 4.86e-08 | 8.95e-07 | 106 |
GO:00062611 | Oral cavity | OSCC | DNA-dependent DNA replication | 84/7305 | 151/18723 | 2.46e-05 | 2.30e-04 | 84 |
GO:000626011 | Oral cavity | LP | DNA replication | 97/4623 | 260/18723 | 3.67e-06 | 7.75e-05 | 97 |
GO:007189715 | Oral cavity | LP | DNA biosynthetic process | 71/4623 | 180/18723 | 8.04e-06 | 1.52e-04 | 71 |
GO:007189722 | Oral cavity | EOLP | DNA biosynthetic process | 33/2218 | 180/18723 | 7.00e-03 | 3.40e-02 | 33 |
GO:00718978 | Prostate | BPH | DNA biosynthetic process | 50/3107 | 180/18723 | 1.06e-04 | 9.73e-04 | 50 |
GO:007189714 | Prostate | Tumor | DNA biosynthetic process | 51/3246 | 180/18723 | 1.63e-04 | 1.46e-03 | 51 |
GO:000626012 | Skin | cSCC | DNA replication | 106/4864 | 260/18723 | 1.18e-07 | 2.77e-06 | 106 |
GO:007189718 | Skin | cSCC | DNA biosynthetic process | 74/4864 | 180/18723 | 6.33e-06 | 8.92e-05 | 74 |
GO:00718974 | Stomach | CAG with IM | DNA biosynthetic process | 19/1050 | 180/18723 | 6.02e-03 | 4.63e-02 | 19 |
GO:007189711 | Stomach | CSG | DNA biosynthetic process | 19/1034 | 180/18723 | 5.12e-03 | 4.17e-02 | 19 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0342022 | Esophagus | ESCC | Nucleotide excision repair | 54/4205 | 63/8465 | 2.01e-09 | 2.17e-08 | 1.11e-08 | 54 |
hsa034104 | Esophagus | ESCC | Base excision repair | 38/4205 | 44/8465 | 3.59e-07 | 2.62e-06 | 1.34e-06 | 38 |
hsa030304 | Esophagus | ESCC | DNA replication | 32/4205 | 36/8465 | 7.71e-07 | 5.06e-06 | 2.59e-06 | 32 |
hsa034304 | Esophagus | ESCC | Mismatch repair | 21/4205 | 23/8465 | 2.85e-05 | 1.35e-04 | 6.90e-05 | 21 |
hsa0342032 | Esophagus | ESCC | Nucleotide excision repair | 54/4205 | 63/8465 | 2.01e-09 | 2.17e-08 | 1.11e-08 | 54 |
hsa0341011 | Esophagus | ESCC | Base excision repair | 38/4205 | 44/8465 | 3.59e-07 | 2.62e-06 | 1.34e-06 | 38 |
hsa0303011 | Esophagus | ESCC | DNA replication | 32/4205 | 36/8465 | 7.71e-07 | 5.06e-06 | 2.59e-06 | 32 |
hsa0343011 | Esophagus | ESCC | Mismatch repair | 21/4205 | 23/8465 | 2.85e-05 | 1.35e-04 | 6.90e-05 | 21 |
hsa03420 | Liver | Cirrhotic | Nucleotide excision repair | 29/2530 | 63/8465 | 4.81e-03 | 1.74e-02 | 1.07e-02 | 29 |
hsa034201 | Liver | Cirrhotic | Nucleotide excision repair | 29/2530 | 63/8465 | 4.81e-03 | 1.74e-02 | 1.07e-02 | 29 |
hsa034204 | Oral cavity | OSCC | Nucleotide excision repair | 49/3704 | 63/8465 | 3.48e-08 | 2.91e-07 | 1.48e-07 | 49 |
hsa03030 | Oral cavity | OSCC | DNA replication | 31/3704 | 36/8465 | 1.70e-07 | 1.19e-06 | 6.03e-07 | 31 |
hsa0342011 | Oral cavity | OSCC | Nucleotide excision repair | 49/3704 | 63/8465 | 3.48e-08 | 2.91e-07 | 1.48e-07 | 49 |
hsa030301 | Oral cavity | OSCC | DNA replication | 31/3704 | 36/8465 | 1.70e-07 | 1.19e-06 | 6.03e-07 | 31 |
hsa0342021 | Oral cavity | LP | Nucleotide excision repair | 37/2418 | 63/8465 | 5.14e-07 | 6.33e-06 | 4.08e-06 | 37 |
hsa030302 | Oral cavity | LP | DNA replication | 23/2418 | 36/8465 | 1.08e-05 | 7.79e-05 | 5.02e-05 | 23 |
hsa034102 | Oral cavity | LP | Base excision repair | 23/2418 | 44/8465 | 7.66e-04 | 3.75e-03 | 2.42e-03 | 23 |
hsa034302 | Oral cavity | LP | Mismatch repair | 12/2418 | 23/8465 | 1.43e-02 | 4.59e-02 | 2.96e-02 | 12 |
hsa0342031 | Oral cavity | LP | Nucleotide excision repair | 37/2418 | 63/8465 | 5.14e-07 | 6.33e-06 | 4.08e-06 | 37 |
hsa030303 | Oral cavity | LP | DNA replication | 23/2418 | 36/8465 | 1.08e-05 | 7.79e-05 | 5.02e-05 | 23 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
POLD4 | SNV | Missense_Mutation | rs140664272 | c.313N>C | p.Tyr105His | p.Y105H | Q9HCU8 | protein_coding | deleterious(0.02) | probably_damaging(0.987) | TCGA-A1-A0SO-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | SD | |
POLD4 | SNV | Missense_Mutation | rs750048961 | c.214N>T | p.Arg72Trp | p.R72W | Q9HCU8 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
POLD4 | SNV | Missense_Mutation | c.294N>T | p.Gln98His | p.Q98H | Q9HCU8 | protein_coding | deleterious(0.01) | probably_damaging(0.996) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
POLD4 | SNV | Missense_Mutation | c.225G>C | p.Gln75His | p.Q75H | Q9HCU8 | protein_coding | tolerated(0.56) | benign(0.014) | TCGA-78-7536-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |